111 related articles for article (PubMed ID: 1696435)
21. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
[TBL] [Abstract][Full Text] [Related]
22. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
Heike Y; Takahashi M; Ohira T; Arioka H; Funayama Y; Nishio K; Ogasawara H; Saijo N
Cancer Chemother Pharmacol; 1995; 35(3):200-4. PubMed ID: 7805177
[TBL] [Abstract][Full Text] [Related]
23. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Chen W; Zhou X; Xu Q; Guo W; Lin L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
[TBL] [Abstract][Full Text] [Related]
25. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
26. Induction of bleomycin resistance in a human oral squamous carcinoma cell line and characterisation of bleomycin-resistant and -sensitive clones.
Urade M; Ogura T; Uematsu T; Takahashi Y; Kishimoto H; Yoshioka W
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):409-14. PubMed ID: 7536509
[TBL] [Abstract][Full Text] [Related]
27. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
30. [Experimental studies on combination chemotherapy of cisplatin with peplomycin against human squamous cell carcinomas in nude mice].
Ekimoto H; Aikawa M; Takahashi K; Matsuda A
Gan To Kagaku Ryoho; 1985 Jan; 12(1):70-6. PubMed ID: 2578275
[TBL] [Abstract][Full Text] [Related]
31. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.
Mese H; Ueyama Y; Suzuki A; Nakayama S; Sasaki A; Hamakawa H; Matsumura T
Chemotherapy; 2001; 47(2):136-42. PubMed ID: 11173816
[TBL] [Abstract][Full Text] [Related]
33. [Antitumor effect of UFT against malignant tumors of maxillary sinus--clinical and biochemical study].
Nakashima T; Matsumura Y; Nomura Y; Komiyama S; Makishima K; Hiroto I
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1729-34. PubMed ID: 7184370
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment for carcinoma of the paranasal sinuses with irradiation and bleomycin.
Matsumura Y; Soda T; Motomura K
Eye Ear Nose Throat Mon; 1973 Jan; 52(1):4-11. PubMed ID: 4122365
[No Abstract] [Full Text] [Related]
35. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Okamura M; Shimada J; Sakagami H
Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
[TBL] [Abstract][Full Text] [Related]
36. Anticancer chemosensitivity changes between the original and recurrent tumors after successful chemotherapy selected according to the sensitivity assay.
Nio Y; Tamura K; Tsubono M; Kawabata K; Masai Y; Hayashi H; Ishigami S; Araya S; Imamura M
Ann Surg; 1995 Jan; 221(1):89-99. PubMed ID: 7826166
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and histopathological study on chemotherapy of maxillary cancer with special reference to bleomycin].
Takasaki K
Nihon Jibiinkoka Gakkai Kaiho; 1971 Jul; 74(7):1129-47. PubMed ID: 4106057
[No Abstract] [Full Text] [Related]
38. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of cisplatin sensitivity and platinum uptake by 40 degrees C hyperthermia in resistant cells.
Ohtsubo T; Saito H; Tanaka N; Matsumoto H; Sugimoto C; Saito T; Hayashi S; Kano E
Cancer Lett; 1997 Oct; 119(1):47-52. PubMed ID: 18372521
[TBL] [Abstract][Full Text] [Related]
40. [Multidisciplinary treatment of maxillary cancer].
Konno A; Hanazawa S; Okamoto Y; Shimada K; Terada N; Togawa K; Kato T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1772-80. PubMed ID: 2439014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
